Phenocell
Adam SKIREDJ
Chief Business Development Officer
Who are we?
PHENOCELL is a biotech company developing state-of-the- art cellular models & bioassays. A unique expertise in stem cells differenciation & a cutting- edge technology (2012 Nobel Prize in Physiology or Medicine), this is the combination we use to develop our products & provide unmatched phenotypic testing services. Our objective is to offer the widest range of first-in-time biological models to foster our clients’ R&D endeavors. To date, our portfolio includes unique human iPSC-derived skin cell lines (e.g. Sebocytes, Keratinocytes & Melanocytes) as well as retinal cells and to say the least, our R&D is highly active. Currently, we are developing second generation models: 3D or pathological for instance. We are allso delighted to develop tailor-made solutions should our clients express specific needs.